Authors
Latest:
George Koshy Vilanilam, MBBS: Migraine as a Risk Factor for Ischemic StrokeThe study found that there has been a significant increasing trend in patients with migraine—irrespective of aura status—having an ischemic stroke.
Latest:
Elizabeth Ross, MD, PhD: Improving the Field By Understanding MechanismsThe director of the Center of Neurogenetics at Weill Cornell Medicine spoke about the wealth of improvements that have really turned this area of medicine into a much more hopeful one.
Latest:
John Didsbury, PhD: Going Against the Grain in Established AlzheimerThe founder and CEO of T3D Therapeutics, Inc., spoke about T3D’s desire to go against the grain and trend in the therapeutic development for mild to moderate Alzheimer disease.
Latest:
Jeremy Payne, MD, PhD: The Lack of Progress for TelestrokeThe director of the Stroke Center at Banner-University Medicine Neuroscience Institute spoke to the need for data like that from the TELECAST study and how the COVID-19 pandemic might push telestroke care forward.
Latest:
Nir Lipsman, MD, PhD: Innovations in Alzheimer DiseaseThe neurosurgeon from Sunnybrook Health Sciences Centre spoke about his excitement about where the medical community is at, at this point, in the understanding of Alzheimer disease.
Latest:
Future Treatment of hATTR AmyloidosisAnalysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
Latest:
Joseph Berger, MD: The Role of Artificial Intelligence in NeurologyThe associate chief of the MS division and professor of neurology at Penn Medicine described the ongoing relationship between artificial intelligence and neurologists, and how it may evolve in the future.
Latest:
Differences in Effective Therapies for Pediatric versus Adults with MS: Brenda Banwell, MDThe chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke at ECTRIMS 2022 about the difference in conversation for therapies between pediatric patients and adult patients with MS. [WATCH TIME: 5 minutes]
Latest:
FDA Approves Pfizer COVID-19 Vaccine for Those Ages 16 Years and OlderThe full approval for BNT162b2 (Comirnaty; Pfizer/BioNTech) will afford physicians greater prescribing capability and is expected to play a role in driving workplace vaccine mandates.
Latest:
The Case for NeurorehabilitationNeurological rehabilitation, or neurorehabilitation, can be described as the use of rehabilitation interventions to improve or maintain function and quality of life in the context of neurological conditions.
Latest:
Significant Impact of Carbidopa Levodopa Agent ND0162 in Parkinson DiseaseThe director of the James J. and Joan A. Gardner Family Center discussed data from the phase 3 BouNDlesstrial assessing a continuous, subcutaneous levodopa/carbidopa delivery system for patients with Parkinson disease experiencing motor fluctuations. [WATCH TIME: 3 minutes]
Latest:
Future Treatment of hATTR AmyloidosisAnalysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
Latest:
Jeff D. Williamson, MD, MHS: SPRINT-MIND Trial Preliminary ResultsThe SPRINT MIND trial found a statistically significant lower rate of new cases of mild cognitive impairment in the intensive treatment group.
Latest:
Elzbieta Kuzma, PhD: Healthy Lifestyle Reduces Dementia Risk Despite GeneticsThe research fellow at the University of Exeter spoke about the findings from her observational study which showed that living a favorable lifestyle could offset the risk for dementia, even if that risk is genetically linked. 


Latest:
Unmet Needs in Narcolepsy and Clinical PearlsNeurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.
Latest:
Amy Sullivan, PysD: Team-Based Approach to MSThe director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about the importance of caring for patients with MS by using a team-based approach.
Latest:
Paroxysmal Abnormalities in the Brain and Defining the ‘Seizure’: Michael Sperling, MDAt the 2022 AES Conference, the Baldwin Keyes professor of neurology at Thomas Jefferson University, talked about what defines a ‘seizure’ and changing the terminology. [WATCH TIME: 5 minutes]
Latest:
J. Eric Pina-Garza, MD: Increasing the Awareness of EpilepsyThe director of Pediatric Epilepsy at Centennial Children's Hospital spoke about the need to increase epilepsy's awareness and the clinical development of several agents that he is keeping his eyes on.
Latest:
Lilyana Amezcua, MD: Better Understanding MS in the Hispanic CommunityThe associate professor of clinical neurology spoke about the need to understand modifiable social and cultural factors that could impact disease severity and progression.
Latest:
Hannah Cock, MD, MBBS: Challenges in Treating Status EpilepticusThe professor of epilepsy and medical education at St. George’s University Hospital London spoke about the number of challenges plaguing epileptologists when treating patients who present with possible status epilepticus in the hospital.
Latest:
Rare Neurologic Diseases Are Not Truly RareDespite being labeled as rare diseases, a number of neurologic conditions impact more patients than most would believe. The consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases, chimed in about how these diseases can often be overlooked.
Latest:
Sumeet Vadera, MD: Advances in Epilepsy SurgeryThe director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.
Latest:
Rebecca Stainman, MD: Identifying, Addressing Physician BurnoutThe child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
Latest:
Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug DevelopmentHaeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.
Latest:
Associations Between Organ Health and Brain Function, Preserving Brain Health: Costantino Iadecola, MDThe director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine spoke about preserving brain function through medical, sociopolitical, and educational efforts as part of his presentation at the 2023 AAN annual meeting. [WATCH TIME: 6 minutes]
